Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash & Equivalents (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Cash & Equivalents for 17 consecutive years, with $158.5 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 73.69% year-over-year to $158.5 million; the TTM value through Mar 2026 reached $158.5 million, up 73.69%, while the annual FY2025 figure was $133.2 million, 74.62% up from the prior year.
  • Cash & Equivalents hit $158.5 million in Q1 2026 for Acadia Healthcare Company, up from $133.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $158.5 million in Q1 2026 and bottomed at $63.8 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $104.8 million, with a median of $99.6 million recorded in 2023.
  • Year-over-year, Cash & Equivalents crashed 54.53% in 2023 and then surged 74.62% in 2025.
  • Acadia Healthcare Company's Cash & Equivalents stood at $97.6 million in 2022, then increased by 2.48% to $100.1 million in 2023, then decreased by 23.75% to $76.3 million in 2024, then soared by 74.62% to $133.2 million in 2025, then increased by 18.94% to $158.5 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $158.5 million, $133.2 million, and $118.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.